Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity

Journal of Immunology

Volumn 156, Issue 1, 1996, Pages 328-335

  McLachlan, Julie A ^a   Serkin, Carla D ^a   Bakouche, Ouahid ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CELL SURFACE PROTEIN; COMPLEMENT COMPONENT C1; ESTROGEN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PRASTERONE; REACTIVE OXYGEN METABOLITE; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL CORTEX; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; RESPIRATORY BURST; STEROIDOGENESIS; TUMOR CELL DESTRUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DEHYDROEPIANDROSTERONE; HUMANS; IMMUNE SERA; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MONOCYTES; NITRITES; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; RECEPTORS, STEROID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030067298     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. 3H]-dehydroepiandrosterone into its principal metabolites in the adrenal cortex of adult castrated male rats and following steroid treatment Endocrinology 121:419
2. Lona, R. M , and D A. Padgett. 1992. Mobilization of cutaneous immunity for systemic protection against infections. Ann. NY Acad. Sci 650:363.
3. Daynes, R A., and B. A. Araneo. 1992 Prevention and reversal of some age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate (DHEAS) therapy Aging, Immunol Infect. Dis. 3:135.
4. Lowisniewski, T., C. W. Hilton, E. V. Morse, and F. Svec. 1993. The relationship to serum DHEA-S and Cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am. J. Med. Sci. 305:79.
5. Christeff, N , S. Gharakhanian, N. Thobie, W. Rozenbaum, and E. A Nunez. 1992 Evidence for changes in adrenal and testicular steroids during HIV infection. J. Acq. Immune Defic. Syndr. 5:841
6. Garg, M., and S Bondada. 1993. Reversal of age-associated decline in immune response to Pnu-imune vaccine by supplementation with the steroid hormone dehydroepiandrosterone. Infect. Immun. 61:2238.
7. Araneo, B A., M. L. Woods II, and R. Daynes. 1993 Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides and adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J. Infect Dix 167.830
8. Daynes, R A., D J. Dudley, and B. A. Araneo. 1990. Regulation of murine lymphokine production in vivo II Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 20-793.
9. Meikle, A. W., R. W. Dorchuck, B. A. Araneo, J. D. Stringham, T. G Evans, S. L Spurance, and R. A. Daynes 1992 The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J. Steroid Biochem. Mol. Biol 42.293.
10. Daynes, R. A., B. A. Araneo, W. B. Ershler, C. Maloney, G. Z. Li, and S. Y Ryu 1993. Altered regulation of IL-6 production with normal aging. J. Immunol 150. 5219.
11. Hennebold, J. D., and R. A. Daynes 1994. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines Endocrinology 135:67.
12. Nathan, C. F., S. C. Silverstein, L. G. Brukner, and Z. A. Cohn 1979. Extracellular cytolysis by activated macrophage and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J. Exp. Med 49:100.
13. Stuehr, D. J., and M. A Marietta. 1987 Induction of nitrite/nitrate synthesis in murine macrophage by BCG infection, lymphokines or interferon-γ. J. Immunol 139:518.
14. Lachman, L. B., C. A. Dinarello, N. D. Llansa, and I. J Fidler. 1986. Natural and recombinant human interleukin 1-β is cytotoxic for human melanoma cells. J. Immunol 136:3098
15. Ziegler-Heitbrock, H. W., A. Moller, R. P. Linke, J. G Haas, E P. Rieber, and G. Riethmuller 1986 Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity. Cancer Res. 46:5947.
16. Philip, R , and L. B. Epstein. 1986. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon, and interleukin-1. Nature 323.86.
17. Ding, A. H., C G Nathan, and D J. Stuehr. 1988 Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophage. J. Immunol. 141.2407
18. Hibbs, J B., Jr., R. R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235.473.
19. Stuehr, D. S . C Morris, and C. F Nathan. 1988. Cytostasis from nitrite, a product of activated macrophage. FASEB J. 2: A1452.
20. Granger, D. L., J. B Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1988. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophage. J Clin Invest. 81.1129.
21. Adams, L. B., J B Hibbs Jr., R R Taintor, and J. L. Kranhenbuhl. 1990. Microbistatic effect of murine-activated macrophage for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725.
22. Berdeaux. A. 1993. Nitric oxide: a ubiquitous messenger Fundamen Clin. Pharmacol 7:401.
23. Brune, B , S. Dinneler, L. Molina y Vedia, and E G. Lapetina. 1994. Nitric oxide, a signal for ADP-ribosylation of proteins. Life Sci 54:61.
24. Cavaillon, J. M , and N. Haeffner-Cavaillon 1990. Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophage. Cytokine 2.313.
25. Knudson, P. J , C. A. Dinarello, and T. B. Strom 1986 Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol 137:3189
26. Bakouche, O., D. C. Brown, and L. B. Lachman. 1987. Subcellular localization of human monocytes interleukin 1: evidence for an inactive precursor molecule and a possible mechanism for IL-1 release J. Immunol. 138:4249.
27. Ichinose, Y , O Bakouche, J. Tsao, and I. J. Fidler. 1988 Tumor necrosis factor and IL-1 associated with plasma membrane of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells, whereas viable activated monocytes lyse both J. Immunol. 141:512.
28. Bakouche, O., Y. Ichinose, R. Heicappell, I. J. Fidler, and L. B. Lachman. 1988. Plasma membrane-associated tumor necrosis factor m human monocytes. a non-integral protein bound to its receptor. J Immunol. 140:1142.
29. Morrey, K. M., C D. Serkin, J. A. McLachlan, and O. Bakouche. 1994. Activation of human monocytes by the pineal hormone melatonin. J. Immunol. 153. 2671
30. Hancock, J. T., L. M. Genderson, and O. T. G. Jones. 1990. Superoxide generation by EBV-transformed B lymphocytes: activation by IL-1β, TNF-α and receptor independent stimuli. Immunology 71:213.
31. Danenberg, H. D., G. Alpert, S. Lustig, and D. Ben-Nathan. 1992 Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production Antimicrob Agents Chemother. 36:2275.
32. Schleimer, R P., G W Lamonica, M. Karin, F Indiveri, G Marone, and M. E. Weksler 1993 Discussion. Eur. J. Clin. Pharmacol. 45.S43.
33. Boccuzzi, G., E. Brignardello, M Di Monaco, C. Forte, L Leonardi, and A. Pizzini. 1992. Influence of dehydroepiandrosterone and 5-en-androstene-3β, 17β-diol on the growth of MCF-7 human breast cancer cells induced by 17β-estradiol Anticancer Res. 12.799
34. Boccuzzi, G., M Aragno, E. Brignardello, E. Tamagno, G. Conti, M, Di Monaco, S Racca, O Danni, and F. Di Carlo. 1992 Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz (A) anthracene-induced rat mammary carcinomas Anticancer Res. 12.1479.
35. Ending, P., and V. A. Koivisto 1994. Physiological importance of dehydroepiandrosterone. Lancet 343:1479.
36. Denis, M 1994. NO or no NO? J. Leukocyte Biol. 55:682.
37. Mautino, G., N. Paul-Eugene, P. Chanez, A. M. Vignola, J. P. Kolb, J Bousquet, and B. Dugas. 1994. Heterogeneous spontaneous and IL-4 induced nitric oxide production by human monocytes. J. Leukocyte Biol. 56:15
38. Essery, S. D., A T Saadi, S J Twite, D. M. Weir, C C. Blackwell, and A. Busuttil. 1994. Lewis antigen expression on human nonocytes and binding of pyrogenic toxins. Agents Actions 41.108.
39. Benes, P., and G. W. Oertel. 1971. Steroid structure and inhibition of glucose-6-phosphate dehydrogenase J. Steroid Biochem. 2:289.
40. Marks, P. H., and J. Banks 1960. Inhibition of mammalian glucose-6-phosphatase dehydrogenase by steroids. Proc. Natl. Acad Sci. USA 46:447.
41. Mohan, P. F., and M. S. Jacobson. 1993. Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Am. J. Med. Sci. 306:10
42. Orentreich, N., J. C. Brind, J. H Vogelman, R. Andres, and H. Baldwin. 1992. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab 75:1002.
43. Salvini, S., M J, Stampfer, R. L. Barbieri, and C H. Hennekens. 1992. Effects of age, smoking and vitamins on plasma DHEAS levels: a cross-sectional study in men. J. Clin. Endocrinol. Metab 74.139.
44. Schutze, S., S Nottrott, K Pfizernmaier, and M. Kronke. 1990. Tumor necrosis factor signal transduction. J. Immunol. 144:2604.
45. Costa-Casnellie, M. R., F. B. Segel, and M. A. Lichtman. 1986. Signal transduction in human monocytes: relationship between superoxide production and the level of kinase C in the membrane. J. Cell. Physiol. 129:336.
46. Myers, M A , L. C. McPhail, and R. Snyderman. 1985. Redistribution of protein kinase C activity in human monocyte: correlation with activation of the respiratory burst. J. Immunol. 135:3411.
47. Wolfson, M., I. Nathan, M. Aharon, A. Dvilansky, and M Aboud. 1993. Synergistic effect of interferon-γ and phorbol myristate acetate on superoxide production by human monocytes. Cell Biol Int. 17:595.
48. Zheleznyak, A , and E J. Brown. 1992. Immunoglobulin-mediated phagocytosis by human monocytes requires protein kinase C activation. J. Biol. Chem. 267: 12042
49. Coffey, R. G., L. L. Weakland, and V. A. Alberts. 1992 Paradoxical stimulation and inhibition by protein kinase C modulating agents of lipopolysacchande evoked production of tumour necrosis factor in human monocytes. Immunology 76:48.
50. Vitté-Mony, I., R Staneou, and J. Bertoglio. 1990. Functional consequences of cAMP accumulation in human NK cells: implications for IL-2 and IL-4 signal transduction J Immunol. 145:4272.
51. Schreck, R , P Tieber, and P. A Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10.2247.
52. Boumpas, D. T., F Paliogianni, E. D. Anastassiou, and J E Balow. 1991. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp. Rheumatol. 9:413.
53. Russo-Marie, F 1992. Macrophage and the glucocorticoids. J. Neuroimmunol. 40:281.
54. Kronenberg, L H., H. M. Rosenblatt, Y. Bryson, and T. C. Mengan. 1982. Interferon: Immunobiology and clinical significance. Ann. Intern. Med. 96:80.
55. Degre, M., and H. Rollag. 1979. Influence of Interferon on the in vivo phagocytic activity of reticulo endothelial system cells. J. Reticuloendothel. Soc. 25:489.
56. Wolfson, M , I. Nathan, M Aharon, A. Dvilansky, and M. Aboud. 1993 Synergistic effect of interferon-γ and phorbol myristate acetate on superoxide production by human monocytes. Cell Biol. Int. 17:595.
57. Williams, J. G., G. J. Jurkovich, and R. V. Maier. 1993. Interferon-γ: a key immunoregulatory lymphokine. J. Surg Res. 54:79.
58. Gametchu, B., C. S Watson, and S. Wu 1993. Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB J 7:1283.